300
Views
33
CrossRef citations to date
0
Altmetric
Theme: Head & Neck Cancer - Review

Sinonasal undifferentiated carcinoma: morphological heterogeneity, diagnosis, management and biological markers

&
Pages 285-296 | Published online: 10 Jan 2014

References

  • Iezzoni JC, Mills SE. ‘Undifferentiated’ small round cell tumors of the sinonasal tract: differential diagnosis update. Am. J. Clin. Pathol. 124(Suppl.), S110–S121 (2005).
  • Dulguerov P, Jacobsen MS, Allal AS, Lehmann W, Calcaterra T. Nasal and paranasal sinus carcinoma: are we making progress? A series of 220 patients and a systematic review. Cancer 92(12), 3012–3029 (2001).
  • Enepekides DJ. Sinonasal undifferentiated carcinoma: an update. Curr. Opin. Otolaryngol. Head Neck Surg. 13(4), 222–225 (2005).
  • Robbins KT, Ferlito A, Silver CE et al. Contemporary management of sinonasal cancer. Head Neck 33(9), 1352–1365 (2011).
  • Franchi A, Miligi L, Palomba A, Giovannetti L, Santucci M. Sinonasal carcinomas: recent advances in molecular and phenotypic characterization and their clinical implications. Crit. Rev. Oncol. Hematol. 79(3), 265–277 (2011).
  • Franchi A, Moroni M, Massi D, Paglierani M, Santucci M. Sinonasal undifferentiated carcinoma, nasopharyngeal-type undifferentiated carcinoma, and keratinizing and nonkeratinizing squamous cell carcinoma express different cytokeratin patterns. Am. J. Surg. Pathol. 26(12), 1597–1604 (2002).
  • Franchi A, Palomba A, Cardesa A. Current diagnostic strategies for undifferentiated tumours of the nasal cavities and paranasal sinuses. Histopathology 59(6), 1034–1045 (2011).
  • Mills SE. Neuroectodermal neoplasms of the head and neck with emphasis on neuroendocrine carcinomas. Mod. Pathol. 15(3), 264–278 (2002).
  • Wenig BM. Undifferentiated malignant neoplasms of the sinonasal tract. Arch. Pathol. Lab. Med. 133(5), 699–712 (2009).
  • French CA. Pathogenesis of NUT midline carcinoma. Annu. Rev. Pathol. 7, 247–265 (2012).
  • Barnes L, Eveson JW, Reichart P et al. (Eds). Head and Neck Tumours. IARC, Lyon, France (2005).
  • Bridge JA, Bowen JM, Smith RB. The small round blue cell tumors of the sinonasal area. Head Neck Pathol. 4(1), 84–93 (2010).
  • Frierson HF Jr, Mills SE, Fechner RE, Taxy JB, Levine PA. Sinonasal undifferentiated carcinoma. An aggressive neoplasm derived from schneiderian epithelium and distinct from olfactory neuroblastoma. Am. J. Surg. Pathol. 10(11), 771–779 (1986).
  • Donald PJ. Sinonasal undifferentiated carcinoma with intracranial extension. Skull Base 16(2), 67–74 (2006).
  • Ejaz A, Wenig BM. Sinonasal undifferentiated carcinoma: clinical and pathologic features and a discussion on classification, cellular differentiation, and differential diagnosis. Adv. Anat. Pathol. 12(3), 134–143 (2005).
  • Lin EM, Sparano A, Spalding A et al. Sinonasal undifferentiated carcinoma: a 13-year experience at a single institution. Skull Base 20(2), 61–67 (2010).
  • Maghami E, Kraus DH. Cancer of the nasal cavity and paranasal sinuses. Expert Rev. Anticancer Ther. 4(3), 411–424 (2004).
  • Cardesa A, Alos L, Franchi A. Nasal cavity and paranasal sinuses. In: Pathology of Head and Neck. Cardesa A, Slootweg P (Eds). Springer, Berlin-Heidelberg, Germany, 58–61 (2006).
  • Franchi A, Palomba A, Fondi C et al. Immunohistochemical investigation of tumorigenic pathways in sinonasal intestinal-type adenocarcinoma. A tissue microarray analysis of 62 cases. Histopathology 59(1), 98–105 (2011).
  • Wadsworth B, Bumpous JM, Martin AW, Nowacki MR, Jenson AB, Farghaly H. Expression of p16 in sinonasal undifferentiated carcinoma (SNUC) without associated human papillomavirus (HPV). Head Neck Pathol. 5(4), 349–354 (2011).
  • Jeng YM, Sung MT, Fang CL et al. Sinonasal undifferentiated carcinoma and nasopharyngeal-type undifferentiated carcinoma: two clinically, biologically, and histopathologically distinct entities. Am. J. Surg. Pathol. 26(3), 371–376 (2002).
  • Bellizzi AM, Bourne TD, Mills SE, Stelow EB. The cytologic features of sinonasal undifferentiated carcinoma and olfactory neuroblastoma. Am. J. Clin. Pathol. 129(3), 367–376 (2008).
  • Faragalla H, Weinreb I. Olfactory neuroblastoma: a review and update. Adv. Anat. Pathol. 16(5), 322–331 (2009).
  • Thompson L. Olfactory neuroblastoma. Ear. Nose. Throat J. 85(9), 569–570 (2006).
  • Thompson LD. Olfactory neuroblastoma. Head Neck Pathol. 3(3), 252–259 (2009).
  • Perez-Ordonez B, Caruana SM, Huvos AG, Shah JP. Small cell neuroendocrine carcinoma of the nasal cavity and paranasal sinuses. Hum. Pathol. 29(8), 826–832 (1998).
  • Miyamoto RC, Gleich LL, Biddinger PW, Gluckman JL. Esthesioneuroblastoma and sinonasal undifferentiated carcinoma: impact of histological grading and clinical staging on survival and prognosis. Laryngoscope 110(8), 1262–1265 (2000).
  • Dawson CW, Port RJ, Young LS. The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC). Semin. Cancer Biol. 22(2), 144–153 (2012).
  • Gil Z, Orr-Urtreger A, Voskoboinik N et al. Cytogenetic analysis of sinonasal carcinomas. Otolaryngol. Head Neck Surg. 134(4), 654–660 (2006).
  • French CA, Kutok JL, Faquin WC et al. Midline carcinoma of children and young adults with NUT rearrangement. J. Clin. Oncol. 22(20), 4135–4139 (2004).
  • Hsieh MS, French CA, Liang CW, Hsiao CH. NUT midline carcinoma: case report and review of the literature. Int. J. Surg. Pathol. 19(6), 808–812 (2011).
  • Stelow EB, Bellizzi AM, Taneja K et al. NUT rearrangement in undifferentiated carcinomas of the upper aerodigestive tract. Am. J. Surg. Pathol. 32(6), 828–834 (2008).
  • Haack H, Johnson LA, Fry CJ et al. Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody. Am. J. Surg. Pathol. 33(7), 984–991 (2009).
  • Mertens F, Wiebe T, Adlercreutz C, Mandahl N, French CA. Successful treatment of a child with t(15;19)-positive tumor. Pediatr. Blood Cancer 49(7), 1015–1017 (2007).
  • Engleson J, Soller M, Panagopoulos I, Dahlén A, Dictor M, Jerkeman M. Midline carcinoma with t(15;19) and BRD4-NUT fusion oncogene in a 30-year-old female with response to docetaxel and radiotherapy. BMC Cancer 6, 69 (2006).
  • Hoffmann M, Klose N, Gottschlich S et al. Detection of human papillomavirus DNA in benign and malignant sinonasal neoplasms. Cancer Lett. 239(1), 64–70 (2006).
  • El-Mofty SK, Lu DW. Prevalence of high-risk human papillomavirus DNA in nonkeratinizing (cylindrical cell) carcinoma of the sinonasal tract: a distinct clinicopathologic and molecular disease entity. Am. J. Surg. Pathol. 29(10), 1367–1372 (2005).
  • Alos L, Moyano S, Nadal A et al. Human papillomaviruses are identified in a subgroup of sinonasal squamous cell carcinomas with favorable outcome. Cancer 115(12), 2701–2709 (2009).
  • López F, Llorente JL, García-Inclán C et al. Genomic profiling of sinonasal squamous cell carcinoma. Head Neck 33(2), 145–153 (2011).
  • López F, Llorente JL, Oviedo CM et al. Gene amplification and protein overexpression of EGFR and ERBB2 in sinonasal squamous cell carcinoma. Cancer 118(7), 1818–1826 (2012).
  • Takahashi Y, Kupferman ME, Bell D et al. Establishment and characterization of novel cell lines from sinonasal undifferentiated carcinoma. Clin. Cancer Res. 18(22), 6178–6187 (2012).
  • Gorelick J, Ross D, Marentette L, Blaivas M. Sinonasal undifferentiated carcinoma: case series and review of the literature. Neurosurgery 47(3), 750–754; discussion 754 (2000).
  • Musy PY, Reibel JF, Levine PA. Sinonasal undifferentiated carcinoma: the search for a better outcome. Laryngoscope 112(8 Pt 1), 1450–1455 (2002).
  • Tanzler ED, Morris CG, Orlando CA, Werning JW, Mendenhall WM. Management of sinonasal undifferentiated carcinoma. Head Neck 30(5), 595–599 (2008).
  • Rischin D, Porceddu S, Peters L, Martin J, Corry J, Weih L. Promising results with chemoradiation in patients with sinonasal undifferentiated carcinoma. Head Neck 26(5), 435–441 (2004).
  • Kouri M, Kankaanranta L, Seppälä T et al. Undifferentiated sinonasal carcinoma may respond to single-fraction boron neutron capture therapy. Radiother. Oncol. 72(1), 83–85 (2004).
  • Chernock RD, Perry A, Pfeifer JD, Holden JA, Lewis JS Jr. Receptor tyrosine kinases in sinonasal undifferentiated carcinomas – evaluation for EGFR, c-KIT, and HER2/neu expression. Head Neck 31(7), 919–927 (2009).
  • Gallo O, Franchi A, Fini-Storchi I et al. Prognostic significance of c-erbB-2 oncoprotein expression in intestinal-type adenocarcinoma of the sinonasal tract. Head Neck 20(3), 224–231 (1998).
  • Franchi A, Fondi C, Paglierani M, Pepi M, Gallo O, Santucci M. Epidermal growth factor receptor expression and gene copy number in sinonasal intestinal type adenocarcinoma. Oral Oncol. 45(9), 835–838 (2009).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.